ABSTRACT
The major and upward trend in the number of published research related to rheumatic and musculoskeletal diseases, in which artificial intelligence plays a key role, has exhibited the interest of rheumatology researchers in using these techniques to answer their research questions. In this review, we analyse the original research articles that combine both worlds in a five-year period (2017-2021). In contrast to other published papers on the same topic, we first studied the review and recommendation articles that were published during that period, including up to October 2022, as well as the publication trends. Secondly, we review the published research articles and classify them into one of the following categories: disease classification, disease prediction, predictors identification, patient stratification and disease subtype identification, disease progression and activity, and treatment response. Thirdly, we provide a table with illustrative studies in which artificial intelligence techniques have played a central role in more than twenty rheumatic and musculoskeletal diseases. Finally, the findings of the research articles, in terms of disease and/or data science techniques employed, are highlighted in a discussion. Therefore, the present review aims to characterise how researchers are applying data science techniques in the rheumatology medical field. The most immediate conclusions that can be drawn from this work are: multiple and novel data science techniques have been used in a wide range of rheumatic and musculoskeletal diseases including rare diseases; the sample size and the data type used are heterogeneous, and new technical approaches are expected to arrive in the short-middle term.
Highlights
The rheumatology research community is increasingly adopting novel AI techniques
There is an upward trend in the number of articles that combine AI and rheumatology
Rheumatic and musculoskeletal rare diseases are gaining from AI techniques
Independent validation of the models should be promoted
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Instituto de Salud Carlos III, Ministry of Health, Madrid, Spain [RD21/002/0001]
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
This work was supported by the Instituto de Salud Carlos III, Ministry of Health, Madrid, Spain [RD21/002/0001]. The sponsor or funding organization had no role in the design or conduct of this research. The journal’s Fee was funded by the institution employing the senior author of the manuscript (Fundación Biomédica del Hospital Clínico San Carlos)
The authors declare there are no competing interests
↵1 First author
↵2 Share senior authorship
content restructuring
Data Availability
All data produced in the present work are contained in the manuscript
